Sacramento Observer
11-02-2006
The pipeline of new lifesaving medicines could be put at risk by quick-fix
solutions such as importing drugs from Canada, say experts from the
Missouri Pharmacy Association.

The connection, experts say, is that costly research and development of new
drugs is borne almost exclusively by pharmaceutical companies, funded by
the sale of their products. When these sales are circumvented, so is the
revenue stream for new medicines.

"We shouldn't take the existence of lifesaving drugs for granted," says the
Association's president, Matt Hartwig. "People are living much longer in
the U.S. compared to previous generations, in part because of new
medicines. Scourges like ...

Related newspaper, magazine, and journal articles:

;

See all results. Or, try our Advanced Search.

We're searching over:

• 60 million articles
• 3,500 publications